PAR1 Inhibition Vorapaxar as a Potential Therapeutic Approach in Chronic Thromboembolic Pulmonary Hypertension - Vienna 2024

Pulmonary hypertension groups 24

Chair(s): Mitja Jevnikar, Fr?d?ric Lador

Session type: Poster session

PAR1 Inhibition Vorapaxar as a Potential Therapeutic Approach in Chronic Thromboembolic Pulmonary Hypertension

Lu Sun

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Hemodynamic measurement in pulmonary hypertension: a challenge for automated CT analysis

Quentin Maloir

Poster

Abstract

Cardiopulmonary exercise test in patients with chronic thromboembolic pulmonary disease and exercise pulmonary hypertension

Adam Dhayyat

Poster

Abstract

Right Ventricular to Pulmonary Circulation Uncoupling Predicts Adverse Outcome in the Heart Failure Patients Cohorts with Highest Left Ventricular Ejection Fraction and Increased Pulmonary Pressure

Saleh Nazzal

Abstract

Epicardial Adipose Tissue Dysfunction in Pulmonary Arterial Hypertension: Implications for Right Ventricular Dysfunction

Sarah-eve Lemay

Abstract

Genome-wide association analyses identified susceptibility loci for chronic thromboembolic pulmonary hypertension among Chinese population

Mengjie Duo

Poster

Abstract

The therapeutic potential of NAMPT in protecting against chronic thromboembolic pulmonary hypertension

Lu Sun

Poster

Abstract

PAR1 Inhibition Vorapaxar as a Potential Therapeutic Approach in Chronic Thromboembolic Pulmonary Hypertension

Lu Sun

Poster

Abstract

Efficacy of pulmonary angioplasty with stent deployment in patients with isolated peripheral pulmonary artery stenosis in adulthood

Misaki Kanezawa

Poster

Abstract

Obstructive sleep apnoea is associated with residual pulmonary hypertension following pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension

Caner ??nar

Poster

Abstract

Estimating pulmonary haemodynamics and vascular resistance in CTEPH from pre- and post-endarterectomy CTPA

Behdad Shaarbaf Ebrahimi

Poster

Abstract

ATMOS, a Proof-of-Concept trial of inhaled mosliciguat in untreated PAH or CTEPH

H. Ardeschir Ghofrani

Poster

Abstract

The Prevalence of Pulmonary Hypertension in Left Heart Disease in Austria, Germany and Switzerland (DACH Region)

Katarina Zeder

Poster

Abstract

Factors associated with oxygenation improvement after balloon pulmonary angioplasty for non-operable chronic thromboembolic pulmonary hypertension.

Yu Taniguchi

Poster

Abstract

Survival is associated with underlying ILD diagnosis in ILD-PH.

Segolene Turquier

Poster

Abstract

The significance of CD16+ monocytes in the occurrence and development of chronic thromboembolic pulmonary hypertension: insights from single-cell RNA sequencing

Maohe Chen

Poster

Abstract

Comparative analysis of circulating endothelial progenitor cells and resected tissue-derived endothelial cells in chronic thromboembolic pulmonary hypertension (CTEPH).

Miriam Peracaula

Poster

Abstract

The impact of the initial treatment of venous thromboembolism on the severity of chronic thromboembolic pulmonary hypertension

Aleksandar Bokan

Poster

Abstract

Clinical and radiological characteristics of CTEPH patients without a history of acute venous thromboembolism

Coen Van Kan

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}